Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AADAT 0.84 0.00129 -0.44 0.14671 miRanda; miRNATAP -0.2 0.00135 NA
2 hsa-miR-590-3p AASS 0.84 0.00129 -0.47 0.07736 MirTarget; miRanda -0.16 0.00457 NA
3 hsa-miR-590-3p ABAT 0.84 0.00129 -0.35 0.20779 PITA; miRanda -0.25 2.0E-5 NA
4 hsa-miR-590-3p ABCA1 0.84 0.00129 -0.92 1.0E-5 miRanda -0.1 0.01762 NA
5 hsa-miR-590-3p ABCA10 0.84 0.00129 -1.84 0 miRanda; mirMAP -0.22 0.00395 NA
6 hsa-miR-590-3p ABCA13 0.84 0.00129 0.37 0.52362 miRanda; mirMAP -0.27 0.02716 NA
7 hsa-miR-590-3p ABCA6 0.84 0.00129 -1.98 0 MirTarget; miRanda -0.34 0 NA
8 hsa-miR-590-3p ABCA8 0.84 0.00129 -4.22 0 miRanda -0.64 0 NA
9 hsa-miR-590-3p ABCA9 0.84 0.00129 -2.24 0 miRanda -0.32 0 NA
10 hsa-miR-590-3p ABCB1 0.84 0.00129 -2.44 0 miRanda -0.17 0.01296 NA
11 hsa-miR-590-3p ABCC3 0.84 0.00129 2.16 0 mirMAP -0.17 0.02116 NA
12 hsa-miR-590-3p ABCC4 0.84 0.00129 -0.61 0.02018 mirMAP -0.14 0.01488 NA
13 hsa-miR-590-3p ABCC9 0.84 0.00129 -1.69 0 miRanda; mirMAP -0.19 0.00172 NA
14 hsa-miR-590-3p ABCG2 0.84 0.00129 -2.65 0 miRanda; mirMAP -0.19 0.00236 NA
15 hsa-miR-590-3p ABHD12B 0.84 0.00129 -1.28 0.00196 miRanda; mirMAP; miRNATAP -0.22 0.01267 NA
16 hsa-miR-590-3p ABHD2 0.84 0.00129 -0.74 0.00059 miRanda; mirMAP -0.16 0.00033 NA
17 hsa-miR-590-3p ABI3BP 0.84 0.00129 -3.27 0 miRanda -0.32 9.0E-5 NA
18 hsa-miR-590-3p ABLIM1 0.84 0.00129 -1.2 0 miRanda; mirMAP -0.15 0.00271 NA
19 hsa-miR-590-3p ACADL 0.84 0.00129 -4.45 0 miRanda -0.42 0.00074 NA
20 hsa-miR-590-3p ACADSB 0.84 0.00129 -0.71 0.001 MirTarget; miRanda; mirMAP -0.23 0 NA
21 hsa-miR-590-3p ACOX2 0.84 0.00129 -0.57 0.05834 miRanda -0.3 0 NA
22 hsa-miR-590-3p ACSL4 0.84 0.00129 -1.28 0 MirTarget; PITA; miRanda; mirMAP -0.1 0.03134 NA
23 hsa-miR-590-3p ACSL5 0.84 0.00129 0.21 0.49172 miRanda; mirMAP -0.18 0.00436 NA
24 hsa-miR-590-3p ACSM5 0.84 0.00129 -1.96 0 miRanda -0.22 0.01346 NA
25 hsa-miR-590-3p ACSS3 0.84 0.00129 -2.44 0 miRanda -0.25 0.00066 NA
26 hsa-miR-590-3p ACTG2 0.84 0.00129 -2.01 0 miRanda -0.32 4.0E-5 NA
27 hsa-miR-590-3p ACVR2A 0.84 0.00129 -0.18 0.16533 MirTarget; PITA; miRanda; miRNATAP -0.1 9.0E-5 NA
28 hsa-miR-590-3p ADAM33 0.84 0.00129 -2.04 0 miRanda -0.31 0.00012 NA
29 hsa-miR-590-3p ADAMTS1 0.84 0.00129 -2.65 0 miRanda -0.28 1.0E-5 NA
30 hsa-miR-590-3p ADAMTS17 0.84 0.00129 -1.08 0.00084 miRanda -0.34 0 NA
31 hsa-miR-590-3p ADAMTS8 0.84 0.00129 -4.68 0 miRanda -0.64 0 NA
32 hsa-miR-590-3p ADAMTS9 0.84 0.00129 -1.27 0 miRanda -0.14 0.01693 NA
33 hsa-miR-590-3p ADAMTSL1 0.84 0.00129 -1.74 0 miRanda; mirMAP -0.23 0.00252 NA
34 hsa-miR-590-3p ADAMTSL3 0.84 0.00129 -3.15 0 miRanda -0.42 0 NA
35 hsa-miR-590-3p ADARB1 0.84 0.00129 -1.88 0 miRanda; mirMAP -0.24 0 NA
36 hsa-miR-590-3p ADCY2 0.84 0.00129 -1.12 0.01473 mirMAP -0.56 0 NA
37 hsa-miR-590-3p ADCY6 0.84 0.00129 -0.15 0.33282 miRanda -0.11 0.00145 NA
38 hsa-miR-590-3p ADCY8 0.84 0.00129 -5.8 0 miRanda -0.32 0.00742 NA
39 hsa-miR-590-3p ADCY9 0.84 0.00129 -1.41 0 miRanda -0.33 0 NA
40 hsa-miR-590-3p ADCYAP1 0.84 0.00129 -1.16 0.01936 MirTarget; PITA; miRanda; miRNATAP -0.4 0.00014 NA
41 hsa-miR-590-3p ADD1 0.84 0.00129 -0.75 0 MirTarget; PITA; miRanda; miRNATAP -0.11 0 NA
42 hsa-miR-590-3p ADH1A 0.84 0.00129 -4.37 0 miRanda -0.59 0 NA
43 hsa-miR-590-3p ADH1B 0.84 0.00129 -4.94 0 miRanda; mirMAP -0.74 0 NA
44 hsa-miR-590-3p ADH6 0.84 0.00129 -1.02 0.10483 miRanda; mirMAP -0.27 0.04676 NA
45 hsa-miR-590-3p ADRB1 0.84 0.00129 -3.81 0 PITA; miRanda; mirMAP; miRNATAP -0.34 0.0011 NA
46 hsa-miR-590-3p ADRB2 0.84 0.00129 -3.46 0 MirTarget; PITA; miRanda -0.37 0 NA
47 hsa-miR-590-3p AFF1 0.84 0.00129 -0.48 0.00026 MirTarget; PITA; miRanda; miRNATAP -0.14 0 NA
48 hsa-miR-590-3p AFF2 0.84 0.00129 -2.23 0 PITA; miRanda; mirMAP; miRNATAP -0.31 0.00129 NA
49 hsa-miR-590-3p AFF3 0.84 0.00129 -3.25 0 PITA; miRanda; mirMAP; miRNATAP -0.51 0 NA
50 hsa-miR-590-3p AFF4 0.84 0.00129 -0.15 0.22477 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.14 0 NA
51 hsa-miR-590-3p AGTR1 0.84 0.00129 -2.83 0 miRanda -0.37 2.0E-5 NA
52 hsa-miR-590-3p AGTR2 0.84 0.00129 -5.08 0 PITA; miRanda -0.45 0.00781 NA
53 hsa-miR-590-3p AHNAK 0.84 0.00129 -2.28 0 miRanda -0.32 0 NA
54 hsa-miR-590-3p AK7 0.84 0.00129 -1.68 1.0E-5 miRanda; mirMAP -0.2 0.01178 NA
55 hsa-miR-590-3p AKAP11 0.84 0.00129 -0.62 0 MirTarget; miRanda; miRNATAP -0.1 0.00013 NA
56 hsa-miR-590-3p AKAP13 0.84 0.00129 -1.2 0 PITA; miRanda; mirMAP -0.25 0 NA
57 hsa-miR-590-3p AKAP2 0.84 0.00129 -2.97 0 mirMAP -0.17 0.00386 NA
58 hsa-miR-590-3p AKAP6 0.84 0.00129 -0.99 0.00066 MirTarget; PITA; miRanda; mirMAP -0.17 0.00614 NA
59 hsa-miR-590-3p ALCAM 0.84 0.00129 -0.7 0.00117 MirTarget; PITA; miRanda; mirMAP -0.15 0.00131 NA
60 hsa-miR-590-3p ALDH3A2 0.84 0.00129 -0.45 0.06236 miRanda -0.16 0.00168 NA
61 hsa-miR-590-3p ALDH6A1 0.84 0.00129 -0.33 0.09417 miRanda -0.16 0.00016 NA
62 hsa-miR-590-3p ALDOB 0.84 0.00129 0.57 0.30252 miRanda -0.31 0.00742 NA
63 hsa-miR-590-3p ALOX15B 0.84 0.00129 -2.01 4.0E-5 miRanda -0.48 0 NA
64 hsa-miR-590-3p ALOX5AP 0.84 0.00129 -2.35 0 miRanda -0.24 0.00013 NA
65 hsa-miR-590-3p AMIGO1 0.84 0.00129 -1.42 0 miRanda -0.24 0 NA
66 hsa-miR-590-3p AMOT 0.84 0.00129 -0.3 0.45043 mirMAP -0.21 0.0156 NA
67 hsa-miR-590-3p AMOTL1 0.84 0.00129 -2.04 0 mirMAP -0.27 0 NA
68 hsa-miR-590-3p ANG 0.84 0.00129 -0.75 0.0061 miRanda -0.12 0.04539 NA
69 hsa-miR-590-3p ANGPT1 0.84 0.00129 -2.86 0 PITA; miRanda; mirMAP -0.4 0 NA
70 hsa-miR-590-3p ANGPTL1 0.84 0.00129 -3.34 0 PITA; miRanda; mirMAP -0.29 0.00011 NA
71 hsa-miR-590-3p ANK2 0.84 0.00129 -1.34 2.0E-5 MirTarget; PITA; miRanda -0.25 0.00011 NA
72 hsa-miR-590-3p ANK3 0.84 0.00129 -1.32 0 MirTarget; PITA; miRanda; mirMAP -0.23 0.0001 NA
73 hsa-miR-590-3p ANKFN1 0.84 0.00129 -1.02 0.06121 miRanda -0.61 0 NA
74 hsa-miR-590-3p ANKFY1 0.84 0.00129 -0.55 0 PITA; miRanda; mirMAP; miRNATAP -0.12 0 NA
75 hsa-miR-590-3p ANKH 0.84 0.00129 0 0.99073 mirMAP; miRNATAP -0.1 0.01507 NA
76 hsa-miR-590-3p ANKHD1 0.84 0.00129 0.11 0.38304 miRanda -0.11 3.0E-5 NA
77 hsa-miR-590-3p ANKMY1 0.84 0.00129 -0.2 0.2373 miRanda; mirMAP -0.13 0.00024 NA
78 hsa-miR-590-3p ANKRD20A3 0.84 0.00129 -1.24 0.00022 miRanda; mirMAP -0.16 0.02485 NA
79 hsa-miR-590-3p ANKRD29 0.84 0.00129 -3.05 0 mirMAP -0.27 0.00335 NA
80 hsa-miR-590-3p ANKRD44 0.84 0.00129 -1.36 0 miRanda -0.16 0.0049 NA
81 hsa-miR-590-3p ANKRD50 0.84 0.00129 -0.3 0.07201 PITA; miRanda; mirMAP -0.14 7.0E-5 NA
82 hsa-miR-590-3p ANKS1A 0.84 0.00129 -1.11 0 PITA; miRanda -0.15 0 NA
83 hsa-miR-590-3p ANO1 0.84 0.00129 -0.71 0.02851 miRanda -0.21 0.002 NA
84 hsa-miR-590-3p ANO2 0.84 0.00129 -2.81 0 miRanda -0.29 2.0E-5 NA
85 hsa-miR-590-3p ANO4 0.84 0.00129 -1.09 0.02542 miRanda -0.35 0.00077 NA
86 hsa-miR-590-3p ANO5 0.84 0.00129 -1.91 2.0E-5 miRanda; mirMAP -0.35 0.00026 NA
87 hsa-miR-590-3p ANO6 0.84 0.00129 -1.11 0 MirTarget; miRanda; mirMAP -0.14 1.0E-5 NA
88 hsa-miR-590-3p ANTXR1 0.84 0.00129 -0.82 0.00129 miRanda; mirMAP -0.22 4.0E-5 NA
89 hsa-miR-590-3p ANTXR2 0.84 0.00129 -0.2 0.28312 PITA; miRanda; mirMAP; miRNATAP -0.12 0.00376 NA
90 hsa-miR-590-3p AOX1 0.84 0.00129 -2.54 0 miRanda -0.31 0.00029 NA
91 hsa-miR-590-3p APBB2 0.84 0.00129 -1.17 0 MirTarget; miRanda; mirMAP; miRNATAP -0.16 1.0E-5 NA
92 hsa-miR-590-3p APC 0.84 0.00129 -0.81 0 PITA; miRanda; mirMAP; miRNATAP -0.21 0 NA
93 hsa-miR-590-3p APOBEC4 0.84 0.00129 -2.81 1.0E-5 miRanda; mirMAP; miRNATAP -0.33 0.01321 NA
94 hsa-miR-590-3p AQP2 0.84 0.00129 -0.41 0.4336 mirMAP -0.31 0.00563 NA
95 hsa-miR-590-3p AQP3 0.84 0.00129 -0.34 0.43722 miRanda -0.48 0 NA
96 hsa-miR-590-3p AQP4 0.84 0.00129 -4.68 0 PITA; miRanda; mirMAP; miRNATAP -0.63 4.0E-5 NA
97 hsa-miR-590-3p AR 0.84 0.00129 -1.82 6.0E-5 mirMAP; miRNATAP -0.5 0 NA
98 hsa-miR-590-3p ARAP3 0.84 0.00129 -1.34 0 mirMAP -0.19 0 NA
99 hsa-miR-590-3p ARHGAP23 0.84 0.00129 -1.29 0 miRanda -0.22 0 NA
100 hsa-miR-590-3p ARHGAP24 0.84 0.00129 -1.71 0 miRanda; mirMAP -0.21 0 NA
101 hsa-miR-590-3p ARHGAP28 0.84 0.00129 -1.3 0 mirMAP -0.17 0.00282 NA
102 hsa-miR-590-3p ARHGAP31 0.84 0.00129 -2.49 0 miRanda; mirMAP; miRNATAP -0.31 0 NA
103 hsa-miR-590-3p ARHGEF10 0.84 0.00129 -1.11 0 miRanda; mirMAP -0.14 0.00074 NA
104 hsa-miR-590-3p ARHGEF12 0.84 0.00129 -0.37 0.00513 PITA; miRanda; mirMAP; miRNATAP -0.16 0 NA
105 hsa-miR-590-3p ARHGEF15 0.84 0.00129 -2.54 0 miRanda; mirMAP -0.27 0 NA
106 hsa-miR-590-3p ARHGEF2 0.84 0.00129 -0.54 0.00067 miRanda; miRNATAP -0.16 0 NA
107 hsa-miR-590-3p ARHGEF37 0.84 0.00129 -1.72 0 mirMAP -0.24 0.00013 NA
108 hsa-miR-590-3p ARHGEF38 0.84 0.00129 0.38 0.1879 mirMAP -0.13 0.02728 NA
109 hsa-miR-590-3p ARHGEF6 0.84 0.00129 -1.67 0 miRanda; mirMAP -0.15 0.00194 NA
110 hsa-miR-590-3p ARHGEF9 0.84 0.00129 -0.32 0.02245 PITA; miRanda; mirMAP; miRNATAP -0.11 0.00022 NA
111 hsa-miR-590-3p ARID4A 0.84 0.00129 -0.6 0 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.14 0 NA
112 hsa-miR-590-3p ARID5B 0.84 0.00129 -0.45 0.00256 mirMAP -0.11 0.00069 NA
113 hsa-miR-590-3p ARL10 0.84 0.00129 -0.26 0.31668 mirMAP -0.2 0.00019 NA
114 hsa-miR-590-3p ARL15 0.84 0.00129 -0.77 0 miRanda; mirMAP -0.14 1.0E-5 NA
115 hsa-miR-590-3p ARMC9 0.84 0.00129 0.02 0.91489 MirTarget; miRanda -0.12 0.00535 NA
116 hsa-miR-590-3p ARMCX2 0.84 0.00129 -0.06 0.76506 miRanda -0.15 0.00035 NA
117 hsa-miR-590-3p ARMCX3 0.84 0.00129 -0.07 0.59101 PITA; miRanda; mirMAP -0.11 3.0E-5 NA
118 hsa-miR-590-3p ARNT2 0.84 0.00129 -1.46 3.0E-5 PITA; miRanda; miRNATAP -0.33 1.0E-5 NA
119 hsa-miR-590-3p ARRDC3 0.84 0.00129 -0.37 0.08066 mirMAP -0.21 0 NA
120 hsa-miR-590-3p ARRDC4 0.84 0.00129 -1.29 0 PITA; miRanda; mirMAP -0.23 0 NA
121 hsa-miR-590-3p ARSD 0.84 0.00129 0.09 0.69508 miRanda -0.17 0.00029 NA
122 hsa-miR-590-3p ARSE 0.84 0.00129 0.64 0.28437 miRanda -0.53 3.0E-5 NA
123 hsa-miR-590-3p ART4 0.84 0.00129 -3.37 0 miRanda -0.39 2.0E-5 NA
124 hsa-miR-590-3p ARX 0.84 0.00129 0.78 0.21807 miRanda -0.32 0.01646 NA
125 hsa-miR-590-3p ASAH1 0.84 0.00129 -1.01 0 miRanda; miRNATAP -0.19 0 NA
126 hsa-miR-590-3p ASB14 0.84 0.00129 0.05 0.79351 miRanda; mirMAP -0.15 0.00037 NA
127 hsa-miR-590-3p ASH1L 0.84 0.00129 0.14 0.3325 MirTarget; PITA; miRanda; miRNATAP -0.13 1.0E-5 NA
128 hsa-miR-590-3p ASPA 0.84 0.00129 -3.23 0 miRanda; mirMAP -0.36 1.0E-5 NA
129 hsa-miR-590-3p ASPN 0.84 0.00129 0.07 0.84432 miRanda -0.2 0.00512 NA
130 hsa-miR-590-3p ASTN1 0.84 0.00129 -2.43 1.0E-5 mirMAP -0.34 0.00331 NA
131 hsa-miR-590-3p ASXL3 0.84 0.00129 -1.18 0.00409 mirMAP -0.33 0.00017 NA
132 hsa-miR-590-3p ATF7 0.84 0.00129 -0.29 0.00533 miRanda; mirMAP -0.15 0 NA
133 hsa-miR-590-3p ATG2B 0.84 0.00129 -0.28 0.02879 miRanda; mirMAP -0.12 1.0E-5 NA
134 hsa-miR-590-3p ATP10A 0.84 0.00129 -1.58 0 PITA; miRanda -0.31 1.0E-5 NA
135 hsa-miR-590-3p ATP10D 0.84 0.00129 -0.72 0.00019 MirTarget; miRanda; mirMAP -0.11 0.00816 NA
136 hsa-miR-590-3p ATP11A 0.84 0.00129 -0.3 0.27412 MirTarget; PITA; miRanda; miRNATAP -0.34 0 NA
137 hsa-miR-590-3p ATP13A4 0.84 0.00129 -2.69 1.0E-5 miRanda -0.68 0 NA
138 hsa-miR-590-3p ATP1B2 0.84 0.00129 -2.08 0 miRanda -0.4 0 NA
139 hsa-miR-590-3p ATP2B4 0.84 0.00129 -0.75 0.00012 mirMAP -0.22 0 NA
140 hsa-miR-590-3p ATP6V0A1 0.84 0.00129 -0.47 0.00046 miRanda -0.15 0 NA
141 hsa-miR-590-3p ATP6V0D2 0.84 0.00129 -0.69 0.09372 miRanda -0.22 0.01087 NA
142 hsa-miR-590-3p ATP8A1 0.84 0.00129 -1.09 0.00028 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.36 0 NA
143 hsa-miR-590-3p ATP8A2 0.84 0.00129 -2 0 PITA; miRanda; mirMAP -0.37 5.0E-5 NA
144 hsa-miR-590-3p ATP8B1 0.84 0.00129 0.31 0.17188 MirTarget; miRanda; miRNATAP -0.13 0.0072 NA
145 hsa-miR-590-3p ATP8B2 0.84 0.00129 -0.33 0.09472 MirTarget; PITA; miRanda; miRNATAP -0.11 0.00784 NA
146 hsa-miR-590-3p ATP9A 0.84 0.00129 0.19 0.28433 miRanda; mirMAP -0.16 1.0E-5 NA
147 hsa-miR-590-3p ATP9B 0.84 0.00129 -0.62 2.0E-5 miRanda -0.14 0 NA
148 hsa-miR-590-3p ATRN 0.84 0.00129 -0.15 0.26372 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.11 0.00018 NA
149 hsa-miR-590-3p ATRX 0.84 0.00129 -0.09 0.47606 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.15 0 NA
150 hsa-miR-590-3p ATXN7 0.84 0.00129 -0.3 0.02008 MirTarget; miRanda; mirMAP; miRNATAP -0.11 6.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 NEUROGENESIS 256 1402 8.579e-33 3.992e-29
2 CARDIOVASCULAR SYSTEM DEVELOPMENT 174 788 3.029e-32 4.698e-29
3 CIRCULATORY SYSTEM DEVELOPMENT 174 788 3.029e-32 4.698e-29
4 CELL DEVELOPMENT 254 1426 9.444e-31 9.163e-28
5 BIOLOGICAL ADHESION 204 1032 9.847e-31 9.163e-28
6 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 280 1672 2.44e-29 1.893e-26
7 REGULATION OF CELL DIFFERENTIATION 255 1492 5.33e-28 3.543e-25
8 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 209 1142 8.674e-27 5.045e-24
9 TISSUE DEVELOPMENT 252 1518 9.949e-26 5.144e-23
10 NEURON DIFFERENTIATION 170 874 8.388e-25 3.903e-22
11 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 234 1395 1.739e-24 7.356e-22
12 VASCULATURE DEVELOPMENT 113 469 1.897e-24 7.356e-22
13 CELLULAR COMPONENT MORPHOGENESIS 166 900 1.098e-21 3.929e-19
14 POSITIVE REGULATION OF CELL DIFFERENTIATION 156 823 1.257e-21 4.177e-19
15 BLOOD VESSEL MORPHOGENESIS 91 364 4.619e-21 1.433e-18
16 HEART DEVELOPMENT 106 466 6.038e-21 1.756e-18
17 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 179 1021 7.597e-21 2.079e-18
18 LOCOMOTION 190 1114 1.032e-20 2.667e-18
19 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 112 513 1.402e-20 3.432e-18
20 ORGAN MORPHOGENESIS 155 841 2.955e-20 6.874e-18
21 CELL PROJECTION ORGANIZATION 162 902 5.589e-20 1.238e-17
22 REGULATION OF CELLULAR COMPONENT MOVEMENT 145 771 7.962e-20 1.684e-17
23 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 206 1275 1.387e-19 2.805e-17
24 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 141 750 2.756e-19 5.343e-17
25 NEURON DEVELOPMENT 132 687 6.16e-19 1.146e-16
26 REGULATION OF NEURON DIFFERENTIATION 113 554 2.338e-18 4.184e-16
27 RESPONSE TO ENDOGENOUS STIMULUS 222 1450 3.303e-18 5.692e-16
28 NEURON PROJECTION DEVELOPMENT 111 545 5.305e-18 8.816e-16
29 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 169 1008 9.952e-18 1.544e-15
30 REGULATION OF CELL DEVELOPMENT 148 836 9.788e-18 1.544e-15
31 CENTRAL NERVOUS SYSTEM DEVELOPMENT 152 872 1.458e-17 2.188e-15
32 CELL MOTILITY 147 835 2.117e-17 2.984e-15
33 LOCALIZATION OF CELL 147 835 2.117e-17 2.984e-15
34 NEURON PROJECTION MORPHOGENESIS 89 402 5.491e-17 7.515e-15
35 TISSUE MORPHOGENESIS 107 533 6.298e-17 8.14e-15
36 HEAD DEVELOPMENT 130 709 6.153e-17 8.14e-15
37 EPITHELIUM DEVELOPMENT 159 945 7.249e-17 8.912e-15
38 MUSCLE STRUCTURE DEVELOPMENT 93 432 7.278e-17 8.912e-15
39 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 93 437 1.579e-16 1.884e-14
40 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 159 957 2.354e-16 2.738e-14
41 EMBRYO DEVELOPMENT 151 894 3.301e-16 3.746e-14
42 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 139 801 5.705e-16 6.32e-14
43 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 125 689 5.867e-16 6.348e-14
44 REGULATION OF PHOSPHORUS METABOLIC PROCESS 233 1618 6.93e-16 7.328e-14
45 POSITIVE REGULATION OF MOLECULAR FUNCTION 251 1791 1.191e-15 1.231e-13
46 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 160 983 1.249e-15 1.264e-13
47 POSITIVE REGULATION OF NEURON DIFFERENTIATION 72 306 1.979e-15 1.955e-13
48 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 81 368 2.017e-15 1.955e-13
49 CELL PART MORPHOGENESIS 116 633 3.303e-15 3.136e-13
50 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 60 232 4.762e-15 4.432e-13
51 UROGENITAL SYSTEM DEVELOPMENT 70 299 6.398e-15 5.837e-13
52 ANGIOGENESIS 69 293 7.31e-15 6.541e-13
53 SYNAPSE ORGANIZATION 45 145 9.889e-15 8.682e-13
54 REGULATION OF NEURON PROJECTION DEVELOPMENT 85 408 1.187e-14 1.022e-12
55 POSITIVE REGULATION OF LOCOMOTION 86 420 2.351e-14 1.989e-12
56 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 252 1848 2.653e-14 2.204e-12
57 TUBE DEVELOPMENT 103 552 3.76e-14 3.069e-12
58 CELL CELL ADHESION 110 608 4.314e-14 3.461e-12
59 POSITIVE REGULATION OF CELL DEVELOPMENT 92 472 6.407e-14 5.053e-12
60 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 229 1656 1.132e-13 8.782e-12
61 REGULATION OF GTPASE ACTIVITY 117 673 1.155e-13 8.813e-12
62 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 68 303 1.385e-13 1.039e-11
63 REGULATION OF CELL PROLIFERATION 210 1496 3.17e-13 2.341e-11
64 REGULATION OF CELL PROJECTION ORGANIZATION 101 558 4.761e-13 3.462e-11
65 EMBRYONIC MORPHOGENESIS 98 539 8.098e-13 5.797e-11
66 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 157 1036 1.084e-12 7.531e-11
67 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 157 1036 1.084e-12 7.531e-11
68 TAXIS 88 464 1.122e-12 7.68e-11
69 RESPONSE TO HORMONE 140 893 1.596e-12 1.063e-10
70 NEGATIVE REGULATION OF CELL DIFFERENTIATION 106 609 1.6e-12 1.063e-10
71 RESPONSE TO GROWTH FACTOR 89 475 1.684e-12 1.103e-10
72 REGULATION OF PROTEIN MODIFICATION PROCESS 230 1710 1.834e-12 1.185e-10
73 REGULATION OF SYSTEM PROCESS 93 507 1.872e-12 1.193e-10
74 FOREBRAIN DEVELOPMENT 73 357 2.36e-12 1.484e-10
75 RESPONSE TO OXYGEN CONTAINING COMPOUND 194 1381 2.682e-12 1.664e-10
76 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 128 799 3.346e-12 2.048e-10
77 MUSCLE TISSUE DEVELOPMENT 61 275 4.254e-12 2.547e-10
78 EMBRYONIC ORGAN DEVELOPMENT 79 406 4.27e-12 2.547e-10
79 SYNAPSE ASSEMBLY 27 69 4.671e-12 2.751e-10
80 RESPONSE TO WOUNDING 99 563 4.816e-12 2.801e-10
81 SENSORY ORGAN DEVELOPMENT 90 493 5.645e-12 3.243e-10
82 PROTEIN PHOSPHORYLATION 144 944 6.155e-12 3.493e-10
83 STEM CELL DIFFERENTIATION 48 190 6.401e-12 3.588e-10
84 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 190 1360 7.6e-12 4.21e-10
85 POSITIVE REGULATION OF CATALYTIC ACTIVITY 207 1518 7.814e-12 4.278e-10
86 INTRACELLULAR SIGNAL TRANSDUCTION 212 1572 1.211e-11 6.555e-10
87 POSITIVE REGULATION OF GENE EXPRESSION 229 1733 1.234e-11 6.598e-10
88 BEHAVIOR 92 516 1.273e-11 6.73e-10
89 REGULATION OF DEVELOPMENTAL GROWTH 62 289 1.292e-11 6.756e-10
90 REGULATION OF HYDROLASE ACTIVITY 185 1327 1.78e-11 9.181e-10
91 POSITIVE REGULATION OF HYDROLASE ACTIVITY 138 905 1.795e-11 9.181e-10
92 POSITIVE REGULATION OF CELL COMMUNICATION 207 1532 1.84e-11 9.308e-10
93 REGULATION OF CELL MORPHOGENESIS 96 552 1.947e-11 9.74e-10
94 RESPONSE TO STEROID HORMONE 89 497 2.173e-11 1.076e-09
95 ACTIN FILAMENT BASED PROCESS 83 450 2.218e-11 1.086e-09
96 RESPONSE TO ORGANIC CYCLIC COMPOUND 139 917 2.326e-11 1.126e-09
97 MESENCHYME DEVELOPMENT 47 190 2.347e-11 1.126e-09
98 MUSCLE CELL DIFFERENTIATION 54 237 2.435e-11 1.156e-09
99 REGULATION OF TRANSPORT 235 1804 2.666e-11 1.253e-09
100 SECOND MESSENGER MEDIATED SIGNALING 42 160 3.52e-11 1.638e-09
101 POSITIVE REGULATION OF MAPK CASCADE 85 470 3.656e-11 1.684e-09
102 RESPONSE TO LIPID 135 888 3.736e-11 1.704e-09
103 SKELETAL SYSTEM DEVELOPMENT 83 455 3.972e-11 1.794e-09
104 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 23 56 5.512e-11 2.466e-09
105 REGULATION OF MEMBRANE POTENTIAL 68 343 5.687e-11 2.52e-09
106 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 41 156 5.767e-11 2.529e-09
107 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 88 498 5.815e-11 2.529e-09
108 CIRCULATORY SYSTEM PROCESS 71 366 6.055e-11 2.609e-09
109 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 52 229 6.494e-11 2.772e-09
110 POSITIVE REGULATION OF RESPONSE TO STIMULUS 246 1929 7.349e-11 3.108e-09
111 REGULATION OF ION TRANSPORT 99 592 9.32e-11 3.907e-09
112 RESPONSE TO ALCOHOL 70 362 9.589e-11 3.984e-09
113 NEGATIVE REGULATION OF CELL DEVELOPMENT 62 303 1.036e-10 4.23e-09
114 CARDIAC MUSCLE TISSUE DEVELOPMENT 38 140 1.032e-10 4.23e-09
115 MESENCHYMAL CELL DIFFERENTIATION 37 134 1.057e-10 4.276e-09
116 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 230 1784 1.221e-10 4.899e-09
117 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 42 166 1.25e-10 4.971e-09
118 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 232 1805 1.339e-10 5.279e-09
119 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 75 404 1.511e-10 5.908e-09
120 REGULATION OF KINASE ACTIVITY 120 776 1.647e-10 6.386e-09
121 REGULATION OF MAPK CASCADE 106 660 2.258e-10 8.684e-09
122 REGULATION OF BLOOD CIRCULATION 60 295 2.664e-10 1.016e-08
123 SENSORY ORGAN MORPHOGENESIS 52 239 3.377e-10 1.278e-08
124 POSITIVE REGULATION OF TRANSPORT 137 936 3.741e-10 1.404e-08
125 REGULATION OF VASCULATURE DEVELOPMENT 51 233 3.983e-10 1.483e-08
126 NEGATIVE REGULATION OF CELL COMMUNICATION 165 1192 4.244e-10 1.567e-08
127 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 55 262 4.338e-10 1.589e-08
128 REGULATION OF EPITHELIAL CELL MIGRATION 41 166 4.583e-10 1.666e-08
129 TELENCEPHALON DEVELOPMENT 50 228 5.508e-10 1.987e-08
130 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 24 67 6.146e-10 2.2e-08
131 REGULATION OF BODY FLUID LEVELS 86 506 7.216e-10 2.563e-08
132 POSITIVE REGULATION OF KINASE ACTIVITY 83 482 7.524e-10 2.652e-08
133 REGULATION OF TRANSMEMBRANE TRANSPORT 76 426 7.656e-10 2.678e-08
134 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 90 541 8.88e-10 3.048e-08
135 CAMERA TYPE EYE MORPHOGENESIS 30 101 8.91e-10 3.048e-08
136 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 90 541 8.88e-10 3.048e-08
137 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 143 1004 1.005e-09 3.413e-08
138 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 46 204 1.033e-09 3.483e-08
139 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 36 138 1.051e-09 3.518e-08
140 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 159 1152 1.122e-09 3.728e-08
141 REGULATION OF ENDOTHELIAL CELL MIGRATION 32 114 1.208e-09 3.988e-08
142 SINGLE ORGANISM BEHAVIOR 70 384 1.394e-09 4.569e-08
143 REGULATION OF EPITHELIAL CELL PROLIFERATION 57 285 1.437e-09 4.676e-08
144 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 30 103 1.502e-09 4.853e-08
145 TUBE MORPHOGENESIS 62 323 1.528e-09 4.902e-08
146 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 38 153 1.661e-09 5.295e-08
147 REGULATION OF HEART CONTRACTION 48 221 1.703e-09 5.389e-08
148 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 194 1492 2.144e-09 6.74e-08
149 EYE DEVELOPMENT 62 326 2.228e-09 6.957e-08
150 CELL CELL SIGNALING 115 767 2.562e-09 7.949e-08
151 CHEMICAL HOMEOSTASIS 127 874 2.675e-09 8.244e-08
152 REGULATION OF CELL ADHESION 99 629 2.703e-09 8.276e-08
153 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 90 554 2.995e-09 9.109e-08
154 POSITIVE REGULATION OF CELL PROLIFERATION 120 814 3.176e-09 9.595e-08
155 MORPHOGENESIS OF AN EPITHELIUM 71 400 3.458e-09 1.038e-07
156 MUSCLE ORGAN DEVELOPMENT 55 277 3.649e-09 1.088e-07
157 KIDNEY EPITHELIUM DEVELOPMENT 33 125 3.72e-09 1.102e-07
158 REGULATION OF GROWTH 99 633 3.793e-09 1.117e-07
159 NEURON PROJECTION GUIDANCE 45 205 3.84e-09 1.124e-07
160 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 55 278 4.175e-09 1.214e-07
161 PATTERN SPECIFICATION PROCESS 73 418 4.291e-09 1.24e-07
162 REGULATION OF WOUND HEALING 33 126 4.628e-09 1.329e-07
163 EMBRYONIC ORGAN MORPHOGENESIS 55 279 4.772e-09 1.362e-07
164 DEVELOPMENTAL GROWTH 62 333 5.24e-09 1.487e-07
165 CELLULAR RESPONSE TO HORMONE STIMULUS 89 552 5.344e-09 1.507e-07
166 CELL PROLIFERATION 103 672 5.5e-09 1.542e-07
167 REGULATION OF RESPONSE TO WOUNDING 72 413 5.912e-09 1.647e-07
168 REGULATION OF CHEMOTAXIS 41 180 6.035e-09 1.671e-07
169 REGULATION OF ACTIN FILAMENT BASED PROCESS 59 312 6.76e-09 1.861e-07
170 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 154 1135 6.845e-09 1.874e-07
171 REGULATION OF HOMEOSTATIC PROCESS 76 447 6.968e-09 1.896e-07
172 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 37 154 7.173e-09 1.94e-07
173 VASCULOGENESIS 21 59 8.238e-09 2.216e-07
174 RESPONSE TO KETONE 41 182 8.486e-09 2.269e-07
175 ION TRANSPORT 167 1262 9.236e-09 2.456e-07
176 EYE MORPHOGENESIS 34 136 9.871e-09 2.61e-07
177 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 125 876 1.077e-08 2.83e-07
178 SPROUTING ANGIOGENESIS 18 45 1.128e-08 2.931e-07
179 GLAND DEVELOPMENT 69 395 1.126e-08 2.931e-07
180 HEART MORPHOGENESIS 45 212 1.151e-08 2.975e-07
181 INOSITOL LIPID MEDIATED SIGNALING 32 124 1.165e-08 2.996e-07
182 CELL FATE COMMITMENT 47 227 1.257e-08 3.213e-07
183 REGULATION OF COAGULATION 26 88 1.318e-08 3.348e-07
184 WOUND HEALING 78 470 1.324e-08 3.348e-07
185 CELLULAR RESPONSE TO NITROGEN COMPOUND 82 505 1.55e-08 3.886e-07
186 REGULATION OF CELL DEATH 188 1472 1.554e-08 3.886e-07
187 NEGATIVE REGULATION OF CELL PROLIFERATION 98 643 1.737e-08 4.323e-07
188 SMOOTHENED SIGNALING PATHWAY 23 72 1.749e-08 4.329e-07
189 POSITIVE REGULATION OF CHEMOTAXIS 31 120 1.912e-08 4.707e-07
190 RESPONSE TO NITROGEN COMPOUND 122 859 2.138e-08 5.235e-07
191 ENDOTHELIUM DEVELOPMENT 26 90 2.209e-08 5.381e-07
192 EAR DEVELOPMENT 42 195 2.252e-08 5.457e-07
193 GROWTH 70 410 2.302e-08 5.551e-07
194 REGULATION OF ORGAN GROWTH 23 73 2.346e-08 5.628e-07
195 AMEBOIDAL TYPE CELL MIGRATION 36 154 2.454e-08 5.855e-07
196 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 14 29 2.661e-08 6.316e-07
197 ORGAN GROWTH 22 68 2.743e-08 6.447e-07
198 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 22 68 2.743e-08 6.447e-07
199 CARDIAC SEPTUM DEVELOPMENT 25 85 2.76e-08 6.454e-07
200 NEGATIVE REGULATION OF LOCOMOTION 51 263 3.016e-08 7.016e-07
201 CYTOSKELETON ORGANIZATION 119 838 3.235e-08 7.488e-07
202 REGULATION OF WNT SIGNALING PATHWAY 57 310 3.402e-08 7.834e-07
203 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 108 740 3.418e-08 7.834e-07
204 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 28 104 3.505e-08 7.994e-07
205 MULTICELLULAR ORGANISMAL SIGNALING 31 123 3.569e-08 8.1e-07
206 RESPONSE TO ACID CHEMICAL 58 319 3.902e-08 8.772e-07
207 REGULATION OF MESENCHYMAL CELL PROLIFERATION 15 34 3.885e-08 8.772e-07
208 ARTERY DEVELOPMENT 23 75 4.147e-08 9.277e-07
209 EXTRACELLULAR STRUCTURE ORGANIZATION 56 304 4.192e-08 9.333e-07
210 REGULATION OF OSSIFICATION 39 178 4.347e-08 9.633e-07
211 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 47 236 4.458e-08 9.832e-07
212 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 43 207 4.681e-08 1.027e-06
213 RETINA DEVELOPMENT IN CAMERA TYPE EYE 32 131 4.81e-08 1.051e-06
214 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 60 337 5.008e-08 1.089e-06
215 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 43 208 5.416e-08 1.172e-06
216 REGULATION OF ION HOMEOSTASIS 42 201 5.61e-08 1.209e-06
217 POSITIVE REGULATION OF GROWTH 47 238 5.838e-08 1.252e-06
218 STRIATED MUSCLE CELL DIFFERENTIATION 38 173 6.01e-08 1.283e-06
219 EPITHELIAL CELL DIFFERENTIATION 79 495 6.061e-08 1.288e-06
220 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 32 133 7.051e-08 1.491e-06
221 NEGATIVE REGULATION OF PHOSPHORYLATION 70 422 7.47e-08 1.566e-06
222 REGULATION OF POTASSIUM ION TRANSPORT 24 83 7.472e-08 1.566e-06
223 RETINA MORPHOGENESIS IN CAMERA TYPE EYE 17 45 7.861e-08 1.64e-06
224 RESPONSE TO EXTERNAL STIMULUS 220 1821 8.383e-08 1.741e-06
225 ACTIVATION OF PROTEIN KINASE ACTIVITY 52 279 8.552e-08 1.768e-06
226 RESPIRATORY SYSTEM DEVELOPMENT 41 197 9.031e-08 1.859e-06
227 PHOSPHORYLATION 159 1228 9.163e-08 1.878e-06
228 RESPONSE TO OXYGEN LEVELS 56 311 9.366e-08 1.911e-06
229 REPRODUCTIVE SYSTEM DEVELOPMENT 68 408 9.502e-08 1.931e-06
230 NEPHRON DEVELOPMENT 29 115 9.629e-08 1.948e-06
231 HOMEOSTATIC PROCESS 170 1337 1.099e-07 2.213e-06
232 REGULATION OF MUSCLE TISSUE DEVELOPMENT 27 103 1.119e-07 2.234e-06
233 REGULATION OF MUSCLE ORGAN DEVELOPMENT 27 103 1.119e-07 2.234e-06
234 MUSCLE SYSTEM PROCESS 52 282 1.222e-07 2.429e-06
235 CYCLIC NUCLEOTIDE METABOLIC PROCESS 19 57 1.41e-07 2.793e-06
236 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 26 98 1.474e-07 2.906e-06
237 CARDIAC MUSCLE CELL DIFFERENTIATION 22 74 1.505e-07 2.955e-06
238 CARDIAC CHAMBER DEVELOPMENT 33 144 1.531e-07 2.993e-06
239 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 24 1.64e-07 3.193e-06
240 REGULATION OF METAL ION TRANSPORT 57 325 1.818e-07 3.524e-06
241 SINGLE ORGANISM CELL ADHESION 73 459 2.205e-07 4.258e-06
242 POSITIVE REGULATION OF ORGAN GROWTH 15 38 2.324e-07 4.468e-06
243 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 17 48 2.355e-07 4.509e-06
244 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 233 1977 2.485e-07 4.739e-06
245 REGULATION OF STEM CELL PROLIFERATION 24 88 2.516e-07 4.778e-06
246 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 125 926 2.579e-07 4.878e-06
247 NEGATIVE REGULATION OF CELL DEATH 119 872 2.847e-07 5.362e-06
248 SEX DIFFERENTIATION 49 266 2.889e-07 5.419e-06
249 DIGESTIVE SYSTEM DEVELOPMENT 33 148 3.022e-07 5.647e-06
250 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 39 191 3.112e-07 5.792e-06
251 CAMP METABOLIC PROCESS 14 34 3.158e-07 5.855e-06
252 REGULATION OF ANATOMICAL STRUCTURE SIZE 74 472 3.242e-07 5.968e-06
253 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 38 184 3.245e-07 5.968e-06
254 MUSCLE CELL DEVELOPMENT 30 128 3.303e-07 6.05e-06
255 GLOMERULUS DEVELOPMENT 17 49 3.317e-07 6.053e-06
256 RENAL SYSTEM PROCESS 26 102 3.479e-07 6.324e-06
257 CARDIOCYTE DIFFERENTIATION 25 96 3.746e-07 6.783e-06
258 SMOOTH MUSCLE CELL DIFFERENTIATION 13 30 4.098e-07 7.39e-06
259 CELL SUBSTRATE ADHESION 35 164 4.117e-07 7.395e-06
260 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 19 61 4.703e-07 8.417e-06
261 REGULATION OF TRANSFERASE ACTIVITY 126 946 4.789e-07 8.537e-06
262 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 44 232 5.005e-07 8.889e-06
263 PALATE DEVELOPMENT 23 85 5.189e-07 9.18e-06
264 REGULATION OF MAP KINASE ACTIVITY 55 319 5.235e-07 9.226e-06
265 RESPONSE TO INORGANIC SUBSTANCE 74 479 5.798e-07 1.014e-05
266 REGULATION OF MUSCLE CELL DIFFERENTIATION 33 152 5.786e-07 1.014e-05
267 RESPONSE TO ESTROGEN 42 218 5.834e-07 1.017e-05
268 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 19 62 6.237e-07 1.083e-05
269 PALLIUM DEVELOPMENT 33 153 6.776e-07 1.172e-05
270 SYSTEM PROCESS 211 1785 8.048e-07 1.387e-05
271 POSITIVE REGULATION OF HEART GROWTH 12 27 8.248e-07 1.416e-05
272 ACTION POTENTIAL 24 94 9.413e-07 1.61e-05
273 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 10 19 9.862e-07 1.681e-05
274 CELL JUNCTION ORGANIZATION 37 185 1.053e-06 1.788e-05
275 REGULATION OF HEART GROWTH 15 42 1.064e-06 1.8e-05
276 CARDIAC CONDUCTION 22 82 1.069e-06 1.802e-05
277 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 20 70 1.108e-06 1.855e-05
278 CELL GROWTH 30 135 1.108e-06 1.855e-05
279 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 87 602 1.132e-06 1.888e-05
280 CELL JUNCTION ASSEMBLY 29 129 1.295e-06 2.147e-05
281 CONNECTIVE TISSUE DEVELOPMENT 38 194 1.296e-06 2.147e-05
282 MUSCLE HYPERTROPHY 12 28 1.33e-06 2.195e-05
283 TRANSMEMBRANE TRANSPORT 140 1098 1.339e-06 2.201e-05
284 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 51 296 1.369e-06 2.243e-05
285 DEVELOPMENTAL CELL GROWTH 21 77 1.395e-06 2.277e-05
286 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 71 465 1.514e-06 2.463e-05
287 MESONEPHROS DEVELOPMENT 23 90 1.549e-06 2.512e-05
288 VENTRICULAR SEPTUM DEVELOPMENT 17 54 1.587e-06 2.563e-05
289 CELLULAR RESPONSE TO LIPID 70 457 1.595e-06 2.568e-05
290 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 88 616 1.603e-06 2.571e-05
291 POSITIVE REGULATION OF OSSIFICATION 22 84 1.665e-06 2.662e-05
292 RHYTHMIC PROCESS 51 298 1.68e-06 2.677e-05
293 GLAND MORPHOGENESIS 24 97 1.732e-06 2.751e-05
294 ENDOTHELIAL CELL DIFFERENTIATION 20 72 1.806e-06 2.848e-05
295 FOREBRAIN GENERATION OF NEURONS 19 66 1.803e-06 2.848e-05
296 MELANOCYTE DIFFERENTIATION 10 20 1.82e-06 2.86e-05
297 CELLULAR RESPONSE TO ACID CHEMICAL 35 175 2.038e-06 3.193e-05
298 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 12 29 2.091e-06 3.265e-05
299 REGULATION OF TRANSPORTER ACTIVITY 38 198 2.177e-06 3.388e-05
300 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 71 470 2.243e-06 3.479e-05
301 CEREBRAL CORTEX DEVELOPMENT 25 105 2.269e-06 3.489e-05
302 MODULATION OF SYNAPTIC TRANSMISSION 51 301 2.272e-06 3.489e-05
303 NEGATIVE CHEMOTAXIS 14 39 2.266e-06 3.489e-05
304 PANCREAS DEVELOPMENT 20 73 2.287e-06 3.5e-05
305 POSITIVE REGULATION OF CELL ADHESION 60 376 2.323e-06 3.543e-05
306 RESPONSE TO CORTICOSTEROID 35 176 2.336e-06 3.553e-05
307 CARTILAGE DEVELOPMENT 31 147 2.416e-06 3.662e-05
308 POSITIVE REGULATION OF MAP KINASE ACTIVITY 39 207 2.584e-06 3.903e-05
309 REGULATION OF VASCULOGENESIS 8 13 2.601e-06 3.917e-05
310 REGULATION OF CYTOPLASMIC TRANSPORT 72 481 2.67e-06 4.007e-05
311 CELLULAR CHEMICAL HOMEOSTASIS 82 570 2.748e-06 4.112e-05
312 NEPHRON EPITHELIUM DEVELOPMENT 23 93 2.853e-06 4.241e-05
313 REGULATION OF SYNAPSE ORGANIZATION 26 113 2.848e-06 4.241e-05
314 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 40 216 3.019e-06 4.474e-05
315 LIPID TRANSLOCATION 10 21 3.205e-06 4.734e-05
316 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 137 1087 3.252e-06 4.789e-05
317 POSITIVE REGULATION OF ENDOCYTOSIS 26 114 3.391e-06 4.977e-05
318 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 49 289 3.493e-06 5.112e-05
319 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 20 75 3.615e-06 5.256e-05
320 NEURAL CREST CELL DIFFERENTIATION 20 75 3.615e-06 5.256e-05
321 REGULATION OF MUSCLE SYSTEM PROCESS 37 195 3.892e-06 5.642e-05
322 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 15 46 3.964e-06 5.713e-05
323 CELLULAR RESPONSE TO PEPTIDE 47 274 3.966e-06 5.713e-05
324 RESPONSE TO ABIOTIC STIMULUS 130 1024 4.046e-06 5.81e-05
325 REGULATION OF CELLULAR LOCALIZATION 156 1277 4.085e-06 5.848e-05
326 REGULATION OF CELL SUBSTRATE ADHESION 34 173 4.255e-06 6.073e-05
327 COGNITION 44 251 4.474e-06 6.366e-05
328 LOCOMOTORY BEHAVIOR 35 181 4.531e-06 6.427e-05
329 REGULATION OF PHOSPHOLIPASE ACTIVITY 18 64 4.835e-06 6.839e-05
330 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 86 616 5.308e-06 7.484e-05
331 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 25 110 5.552e-06 7.805e-05
332 CALCIUM MEDIATED SIGNALING 22 90 5.72e-06 8.017e-05
333 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 21 84 6.346e-06 8.867e-05
334 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 25 111 6.587e-06 9.176e-05
335 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 11 27 6.717e-06 9.33e-05
336 REGULATION OF MEMBRANE LIPID DISTRIBUTION 13 37 6.863e-06 9.503e-05
337 NEGATIVE REGULATION OF COAGULATION 15 48 7.179e-06 9.912e-05
338 REGULATION OF PROTEIN LOCALIZATION 121 950 7.52e-06 0.0001035
339 ORGANIC HYDROXY COMPOUND TRANSPORT 31 155 7.654e-06 0.0001051
340 REGULATION OF OSTEOBLAST DIFFERENTIATION 25 112 7.794e-06 0.0001063
341 LENS DEVELOPMENT IN CAMERA TYPE EYE 18 66 7.784e-06 0.0001063
342 STEM CELL PROLIFERATION 17 60 7.911e-06 0.0001076
343 VASCULAR PROCESS IN CIRCULATORY SYSTEM 32 163 8.245e-06 0.0001118
344 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 29 141 8.446e-06 0.0001139
345 OLFACTORY BULB INTERNEURON DEVELOPMENT 7 11 8.449e-06 0.0001139
346 REGULATION OF SYNAPSE ASSEMBLY 20 79 8.538e-06 0.0001148
347 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 23 99 8.826e-06 0.000118
348 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 23 99 8.826e-06 0.000118
349 CARDIAC VENTRICLE DEVELOPMENT 24 106 9.093e-06 0.0001212
350 RESPONSE TO MECHANICAL STIMULUS 38 210 9.234e-06 0.0001228
351 REGULATION OF HEART RATE 21 86 9.43e-06 0.000125
352 CARDIAC SEPTUM MORPHOGENESIS 15 49 9.526e-06 0.0001256
353 CARDIAC CELL DEVELOPMENT 15 49 9.526e-06 0.0001256
354 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 17 61 1.009e-05 0.0001319
355 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 16 55 1.004e-05 0.0001319
356 POSITIVE REGULATION OF STEM CELL PROLIFERATION 17 61 1.009e-05 0.0001319
357 VENTRICULAR SEPTUM MORPHOGENESIS 11 28 1.02e-05 0.000133
358 OLFACTORY BULB INTERNEURON DIFFERENTIATION 8 15 1.111e-05 0.0001438
359 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 8 15 1.111e-05 0.0001438
360 DIVALENT INORGANIC CATION TRANSPORT 45 268 1.112e-05 0.0001438
361 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 25 115 1.272e-05 0.0001635
362 RESPONSE TO CALCIUM ION 25 115 1.272e-05 0.0001635
363 FOREBRAIN CELL MIGRATION 17 62 1.28e-05 0.0001635
364 ACTIN FILAMENT ORGANIZATION 33 174 1.283e-05 0.0001635
365 REGIONALIZATION 50 311 1.277e-05 0.0001635
366 LONG TERM SYNAPTIC POTENTIATION 13 39 1.328e-05 0.0001689
367 REGULATION OF ODONTOGENESIS 10 24 1.4e-05 0.0001775
368 CANONICAL WNT SIGNALING PATHWAY 22 95 1.45e-05 0.0001834
369 FOREBRAIN NEURON DEVELOPMENT 12 34 1.47e-05 0.0001854
370 FEMALE SEX DIFFERENTIATION 25 116 1.49e-05 0.0001874
371 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 24 109 1.501e-05 0.0001883
372 POSITIVE REGULATION OF AXONOGENESIS 18 69 1.526e-05 0.0001908
373 REGULATION OF AXONOGENESIS 32 168 1.574e-05 0.0001963
374 CALCIUM ION TRANSPORT 39 223 1.614e-05 0.0002008
375 SECRETION 81 588 1.624e-05 0.0002014
376 ARTERY MORPHOGENESIS 15 51 1.635e-05 0.0002014
377 REGULATION OF CELL GROWTH 59 391 1.629e-05 0.0002014
378 MULTICELLULAR ORGANISMAL HOMEOSTASIS 45 272 1.636e-05 0.0002014
379 ENDOTHELIAL CELL MIGRATION 16 57 1.656e-05 0.0002033
380 REGULATION OF CALCIUM MEDIATED SIGNALING 19 76 1.729e-05 0.0002117
381 NEURON MIGRATION 24 110 1.765e-05 0.0002156
382 REGULATION OF BLOOD PRESSURE 32 169 1.784e-05 0.0002173
383 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 9 20 1.796e-05 0.0002176
384 TRACHEA DEVELOPMENT 9 20 1.796e-05 0.0002176
385 MUSCLE ORGAN MORPHOGENESIS 18 70 1.89e-05 0.0002284
386 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 31 162 1.93e-05 0.0002327
387 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 45 274 1.976e-05 0.0002376
388 CARDIAC CHAMBER MORPHOGENESIS 23 104 2.081e-05 0.0002496
389 NEGATIVE REGULATION OF WOUND HEALING 16 58 2.105e-05 0.0002512
390 EMBRYONIC PATTERN SPECIFICATION 16 58 2.105e-05 0.0002512
391 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 11 30 2.208e-05 0.0002627
392 RESPONSE TO PEPTIDE 60 404 2.253e-05 0.0002674
393 TISSUE MIGRATION 20 84 2.276e-05 0.0002695
394 LEUKOCYTE MIGRATION 43 259 2.29e-05 0.0002704
395 CELL MATRIX ADHESION 25 119 2.365e-05 0.0002786
396 REGULATION OF MEMBRANE DEPOLARIZATION 13 41 2.447e-05 0.0002868
397 LUNG ALVEOLUS DEVELOPMENT 13 41 2.447e-05 0.0002868
398 SECRETION BY CELL 69 486 2.57e-05 0.0002998
399 RENAL TUBULE DEVELOPMENT 19 78 2.569e-05 0.0002998
400 IN UTERO EMBRYONIC DEVELOPMENT 49 311 2.676e-05 0.0003113
401 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 15 53 2.717e-05 0.0003153
402 REGULATION OF DENDRITE DEVELOPMENT 25 120 2.746e-05 0.0003178
403 OVULATION CYCLE 24 113 2.828e-05 0.0003266
404 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 12 36 2.852e-05 0.0003284
405 SPINAL CORD DEVELOPMENT 23 106 2.877e-05 0.0003306
406 LIPID PHOSPHORYLATION 22 99 2.885e-05 0.0003306
407 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 35 197 3.057e-05 0.0003495
408 CATION TRANSPORT 102 796 3.064e-05 0.0003495
409 HEART GROWTH 10 26 3.229e-05 0.0003674
410 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 16 60 3.339e-05 0.0003789
411 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 22 100 3.401e-05 0.000385
412 DIGESTIVE TRACT MORPHOGENESIS 14 48 3.457e-05 0.0003894
413 POSITIVE REGULATION OF WOUND HEALING 14 48 3.457e-05 0.0003894
414 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 28 144 3.543e-05 0.0003972
415 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 28 144 3.543e-05 0.0003972
416 NEGATIVE REGULATION OF PLATELET ACTIVATION 8 17 3.585e-05 0.0003991
417 REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE 8 17 3.585e-05 0.0003991
418 MORPHOGENESIS OF A BRANCHING STRUCTURE 31 167 3.577e-05 0.0003991
419 CELLULAR HOMEOSTASIS 89 676 3.621e-05 0.0004021
420 CELL PROJECTION ASSEMBLY 43 264 3.663e-05 0.0004058
421 REGULATION OF PROTEIN IMPORT 33 183 3.742e-05 0.0004136
422 CORONARY VASCULATURE DEVELOPMENT 12 37 3.891e-05 0.000426
423 CARDIAC MUSCLE CELL ACTION POTENTIAL 12 37 3.891e-05 0.000426
424 REGULATION OF INTRACELLULAR TRANSPORT 83 621 3.865e-05 0.000426
425 CAMP MEDIATED SIGNALING 12 37 3.891e-05 0.000426
426 REGULATION OF PROTEIN TARGETING 48 307 3.929e-05 0.0004291
427 RESPONSE TO METAL ION 51 333 4.007e-05 0.0004367
428 WNT SIGNALING PATHWAY 53 351 4.222e-05 0.000459
429 ION TRANSMEMBRANE TRANSPORT 104 822 4.319e-05 0.0004685
430 ACTIN CYTOSKELETON REORGANIZATION 15 55 4.388e-05 0.0004748
431 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 14 49 4.458e-05 0.0004791
432 DIVALENT INORGANIC CATION HOMEOSTASIS 52 343 4.458e-05 0.0004791
433 CELLULAR RESPONSE TO CALCIUM ION 14 49 4.458e-05 0.0004791
434 METANEPHROS DEVELOPMENT 19 81 4.514e-05 0.000483
435 REGULATION OF SECRETION 91 699 4.534e-05 0.000483
436 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 9 22 4.536e-05 0.000483
437 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 9 22 4.536e-05 0.000483
438 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 26 131 4.616e-05 0.0004904
439 ESTABLISHMENT OF CELL POLARITY 20 88 4.667e-05 0.0004947
440 AXIS ELONGATION 10 27 4.734e-05 0.0005006
441 REGULATION OF ORGAN MORPHOGENESIS 40 242 4.815e-05 0.0005081
442 REGULATION OF CELLULAR COMPONENT BIOGENESIS 98 767 4.891e-05 0.0005149
443 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 30 162 4.971e-05 0.0005221
444 SPECIFICATION OF SYMMETRY 24 117 5.132e-05 0.0005377
445 OSSIFICATION 41 251 5.143e-05 0.0005377
446 REGULATION OF MUSCLE CONTRACTION 28 147 5.209e-05 0.0005434
447 KIDNEY MORPHOGENESIS 19 82 5.406e-05 0.0005627
448 EPITHELIAL TO MESENCHYMAL TRANSITION 15 56 5.52e-05 0.0005733
449 EPITHELIAL CELL PROLIFERATION 20 89 5.538e-05 0.000574
450 ANION TRANSPORT 70 507 5.567e-05 0.0005757
451 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 89 684 5.588e-05 0.0005765
452 NEURAL RETINA DEVELOPMENT 14 50 5.705e-05 0.0005873
453 PLASMA MEMBRANE ORGANIZATION 35 203 5.807e-05 0.0005965
454 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 8 18 5.965e-05 0.0006099
455 METAL ION TRANSPORT 78 582 5.975e-05 0.0006099
456 POSITIVE REGULATION OF ION TRANSPORT 39 236 5.977e-05 0.0006099
457 BONE DEVELOPMENT 29 156 6.128e-05 0.0006237
458 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 11 33 6.139e-05 0.0006237
459 REGULATION OF CARTILAGE DEVELOPMENT 16 63 6.383e-05 0.0006457
460 NEUROEPITHELIAL CELL DIFFERENTIATION 16 63 6.383e-05 0.0006457
461 REGULATION OF LIPASE ACTIVITY 19 83 6.451e-05 0.0006511
462 AXIS SPECIFICATION 20 90 6.551e-05 0.0006598
463 REGULATION OF LEUKOCYTE MIGRATION 28 149 6.683e-05 0.0006716
464 REGULATION OF PHOSPHOLIPASE C ACTIVITY 12 39 6.983e-05 0.0006973
465 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 7 14 6.962e-05 0.0006973
466 ASTROCYTE DIFFERENTIATION 12 39 6.983e-05 0.0006973
467 EAR MORPHOGENESIS 23 112 7.162e-05 0.0007136
468 EXOCRINE SYSTEM DEVELOPMENT 13 45 7.314e-05 0.0007272
469 NEGATIVE REGULATION OF TRANSPORT 64 458 8.008e-05 0.0007945
470 NEGATIVE REGULATION OF GENE EXPRESSION 170 1493 8.153e-05 0.0008071
471 RESPONSE TO FLUID SHEAR STRESS 11 34 8.372e-05 0.000827
472 ADHERENS JUNCTION ORGANIZATION 17 71 8.502e-05 0.0008382
473 PROTEIN LOCALIZATION TO CELL PERIPHERY 28 151 8.521e-05 0.0008382
474 REGULATION OF JNK CASCADE 29 159 8.74e-05 0.000858
475 REGULATION OF ENDOCYTOSIS 34 199 8.855e-05 0.0008674
476 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 21 99 8.919e-05 0.0008718
477 GLIOGENESIS 31 175 8.962e-05 0.0008742
478 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 24 121 8.994e-05 0.0008755
479 INNER EAR MORPHOGENESIS 20 92 9.082e-05 0.0008822
480 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 14 52 9.135e-05 0.0008855
481 DEVELOPMENTAL PIGMENTATION 12 40 9.199e-05 0.0008895
482 REGULATED EXOCYTOSIS 37 224 9.214e-05 0.0008895
483 KIDNEY VASCULATURE DEVELOPMENT 8 19 9.526e-05 0.0009158
484 RENAL SYSTEM VASCULATURE DEVELOPMENT 8 19 9.526e-05 0.0009158
485 PIGMENT CELL DIFFERENTIATION 10 29 9.576e-05 0.0009187
486 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 28 152 9.601e-05 0.0009192
487 MUSCLE CONTRACTION 38 233 9.835e-05 0.0009397
488 REGULATION OF POSITIVE CHEMOTAXIS 9 24 0.0001017 0.0009681
489 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 9 24 0.0001017 0.0009681
490 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 24 122 0.000103 0.0009777
491 PIGMENTATION 19 86 0.0001074 0.001018
492 HEMOSTASIS 47 311 0.0001095 0.001036
493 REGENERATION 29 161 0.00011 0.001038
494 APPENDAGE DEVELOPMENT 30 169 0.0001111 0.001044
495 LIMB DEVELOPMENT 30 169 0.0001111 0.001044
496 RESPONSE TO MINERALOCORTICOID 11 35 0.0001126 0.001057
497 MESONEPHRIC TUBULE MORPHOGENESIS 14 53 0.0001144 0.001071
498 ENDOCRINE SYSTEM DEVELOPMENT 24 123 0.0001176 0.001099
499 RESPONSE TO ESTRADIOL 27 146 0.0001185 0.001105
500 CELL SUBSTRATE JUNCTION ASSEMBLY 12 41 0.0001199 0.001116
501 ION HOMEOSTASIS 76 576 0.0001226 0.001139
502 EPITHELIAL CELL DEVELOPMENT 32 186 0.0001231 0.001139
503 POSITIVE REGULATION OF RESPONSE TO WOUNDING 29 162 0.0001231 0.001139
504 REGULATION OF SMOOTH MUSCLE CONTRACTION 15 60 0.00013 0.001198
505 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 15 60 0.00013 0.001198
506 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 34 203 0.0001321 0.001215
507 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 10 30 0.0001326 0.001217
508 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 28 155 0.0001361 0.001247
509 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 36 220 0.0001382 0.001263
510 CARDIAC MUSCLE TISSUE MORPHOGENESIS 14 54 0.0001423 0.001298
511 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 23 117 0.0001438 0.00131
512 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 9 25 0.0001469 0.001328
513 MEMBRANE ASSEMBLY 9 25 0.0001469 0.001328
514 REGULATION OF ACUTE INFLAMMATORY RESPONSE 17 74 0.000147 0.001328
515 REGULATION OF SYNAPTIC PLASTICITY 26 140 0.0001463 0.001328
516 OVULATION CYCLE PROCESS 19 88 0.0001484 0.001338
517 POSITIVE CHEMOTAXIS 11 36 0.0001497 0.001347
518 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 28 156 0.0001525 0.00137
519 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 30 172 0.0001538 0.001379
520 MULTI MULTICELLULAR ORGANISM PROCESS 35 213 0.0001563 0.001398
521 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 33 197 0.0001642 0.001466
522 SYNAPTIC SIGNALING 59 424 0.0001677 0.001494
523 NEURAL TUBE DEVELOPMENT 27 149 0.0001685 0.001499
524 REGULATION OF PLATELET ACTIVATION 10 31 0.0001807 0.001605
525 REGULATION OF BINDING 43 283 0.0001863 0.001651
526 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 13 49 0.0001899 0.00168
527 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 15 62 0.000193 0.001704
528 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 54 381 0.000195 0.001718
529 REGULATION OF MUSCLE HYPERTROPHY 11 37 0.0001965 0.001728
530 SULFATION 7 16 0.0001988 0.001736
531 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 12 43 0.0001981 0.001736
532 NEURON CELL CELL ADHESION 7 16 0.0001988 0.001736
533 REGULATION OF DEVELOPMENTAL PIGMENTATION 7 16 0.0001988 0.001736
534 REGULATION OF CELL MATRIX ADHESION 19 90 0.0002026 0.001765
535 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 25 135 0.0002037 0.001768
536 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 16 69 0.0002033 0.001768
537 REGULATION OF CELL FATE COMMITMENT 9 26 0.0002075 0.001798
538 CELLULAR RESPONSE TO OXYGEN LEVELS 26 143 0.0002085 0.001804
539 NEGATIVE REGULATION OF KINASE ACTIVITY 39 250 0.0002096 0.001809
540 REPRODUCTION 148 1297 0.0002162 0.001863
541 HEPATICOBILIARY SYSTEM DEVELOPMENT 24 128 0.0002226 0.001914
542 GLIAL CELL DIFFERENTIATION 25 136 0.0002295 0.00197
543 REGULATION OF CALCIUM ION TRANSPORT 34 209 0.000234 0.002005
544 DORSAL VENTRAL PATTERN FORMATION 19 91 0.0002357 0.002008
545 ENSHEATHMENT OF NEURONS 19 91 0.0002357 0.002008
546 AXON ENSHEATHMENT 19 91 0.0002357 0.002008
547 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 13 50 0.0002366 0.002009
548 RESPONSE TO PROGESTERONE 13 50 0.0002366 0.002009
549 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 6 12 0.0002381 0.002014
550 AXON EXTENSION INVOLVED IN AXON GUIDANCE 6 12 0.0002381 0.002014
551 ENDOCARDIAL CUSHION DEVELOPMENT 10 32 0.0002427 0.002038
552 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 18 84 0.0002425 0.002038
553 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 18 84 0.0002425 0.002038
554 NEURAL PRECURSOR CELL PROLIFERATION 16 70 0.0002427 0.002038
555 DIENCEPHALON DEVELOPMENT 17 77 0.0002453 0.002056
556 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 35 218 0.0002476 0.002072
557 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 12 44 0.0002512 0.002098
558 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 68 514 0.0002528 0.002108
559 BONE MINERALIZATION 11 38 0.0002552 0.002117
560 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 38 0.0002552 0.002117
561 REGULATION OF RENAL SYSTEM PROCESS 11 38 0.0002552 0.002117
562 REGULATION OF CELLULAR PROTEIN LOCALIZATION 72 552 0.0002585 0.00214
563 REGULATION OF EMBRYONIC DEVELOPMENT 22 114 0.0002618 0.002164
564 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 23 122 0.0002744 0.002264
565 RESPONSE TO RETINOIC ACID 21 107 0.0002812 0.002312
566 PLATELET DEGRANULATION 21 107 0.0002812 0.002312
567 REGULATION OF CATENIN IMPORT INTO NUCLEUS 9 27 0.0002876 0.00236
568 SOMITE DEVELOPMENT 17 78 0.0002888 0.002366
569 CELL CHEMOTAXIS 28 162 0.0002931 0.002386
570 CELLULAR RESPONSE TO INSULIN STIMULUS 26 146 0.0002933 0.002386
571 NEURAL CREST CELL MIGRATION 13 51 0.0002928 0.002386
572 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 28 162 0.0002931 0.002386
573 CELLULAR RESPONSE TO ALCOHOL 22 115 0.0002978 0.002418
574 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 20 100 0.0002997 0.002429
575 CAMP BIOSYNTHETIC PROCESS 7 17 0.0003129 0.002519
576 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 7 17 0.0003129 0.002519
577 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 7 17 0.0003129 0.002519
578 DORSAL VENTRAL NEURAL TUBE PATTERNING 7 17 0.0003129 0.002519
579 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 24 131 0.0003194 0.002567
580 NEURON RECOGNITION 10 33 0.0003215 0.002579
581 REGULATION OF CELL SHAPE 25 139 0.000325 0.002603
582 ACTIVATION OF ADENYLATE CYCLASE ACTIVITY 11 39 0.000328 0.002613
583 COCHLEA DEVELOPMENT 11 39 0.000328 0.002613
584 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 11 39 0.000328 0.002613
585 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 42 282 0.0003392 0.002694
586 ERBB SIGNALING PATHWAY 17 79 0.0003389 0.002694
587 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 27 156 0.0003643 0.002887
588 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 21 109 0.0003661 0.002892
589 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 21 109 0.0003661 0.002892
590 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 18 87 0.0003828 0.002985
591 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 18 87 0.0003828 0.002985
592 REGULATION OF CELLULAR COMPONENT SIZE 48 337 0.0003836 0.002985
593 VIRAL ENTRY INTO HOST CELL 18 87 0.0003828 0.002985
594 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 18 87 0.0003828 0.002985
595 MAMMARY GLAND DEVELOPMENT 22 117 0.0003831 0.002985
596 MOVEMENT IN HOST ENVIRONMENT 18 87 0.0003828 0.002985
597 ENTRY INTO HOST 18 87 0.0003828 0.002985
598 ENTRY INTO HOST CELL 18 87 0.0003828 0.002985
599 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 9 28 0.0003916 0.003042
600 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 20 102 0.0003936 0.003053
601 MESODERM MORPHOGENESIS 15 66 0.0004012 0.003095
602 POSITIVE REGULATION OF LIPASE ACTIVITY 15 66 0.0004012 0.003095
603 REGULATION OF CARDIAC CONDUCTION 15 66 0.0004012 0.003095
604 POSITIVE REGULATION OF PROTEIN BINDING 16 73 0.0004032 0.003096
605 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 24 133 0.0004029 0.003096
606 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 24 133 0.0004029 0.003096
607 SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL INTERNEURON MIGRATION 6 13 0.0004099 0.003127
608 SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION 6 13 0.0004099 0.003127
609 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 31 190 0.0004095 0.003127
610 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 6 13 0.0004099 0.003127
611 MAMMARY GLAND MORPHOGENESIS 11 40 0.0004175 0.003175
612 ENDOCRINE PANCREAS DEVELOPMENT 11 40 0.0004175 0.003175
613 ORGAN FORMATION 10 34 0.0004206 0.003177
614 ADHERENS JUNCTION ASSEMBLY 10 34 0.0004206 0.003177
615 CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS 10 34 0.0004206 0.003177
616 NEURAL TUBE PATTERNING 10 34 0.0004206 0.003177
617 MESODERM DEVELOPMENT 22 118 0.0004332 0.003267
618 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 13 53 0.0004397 0.003311
619 SMOOTH MUSCLE TISSUE DEVELOPMENT 7 18 0.000474 0.003552
620 CELL CELL JUNCTION ASSEMBLY 16 74 0.0004738 0.003552
621 INOSITOL PHOSPHATE MEDIATED SIGNALING 7 18 0.000474 0.003552
622 REGULATION OF NEURON APOPTOTIC PROCESS 31 192 0.0004925 0.003684
623 POSITIVE REGULATION OF BINDING 23 127 0.0004996 0.003726
624 NEGATIVE REGULATION OF ION TRANSPORT 23 127 0.0004996 0.003726
625 CARDIAC MUSCLE CELL CONTRACTION 9 29 0.0005248 0.0039
626 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 9 29 0.0005248 0.0039
627 AORTA DEVELOPMENT 11 41 0.0005267 0.003908
628 MONOSACCHARIDE TRANSPORT 13 54 0.000534 0.003957
629 REGULATION OF PROTEIN BINDING 28 168 0.0005382 0.003981
630 DEVELOPMENTAL MATURATION 31 193 0.0005393 0.003983
631 LIPID MODIFICATION 33 210 0.0005429 0.004003
632 NEGATIVE REGULATION OF GROWTH 36 236 0.0005541 0.004079
633 REGULATION OF PHOSPHATASE ACTIVITY 23 128 0.0005603 0.004119
634 REGULATION OF PROTEIN SECRETION 53 389 0.0005831 0.004279
635 ANTERIOR POSTERIOR PATTERN SPECIFICATION 31 194 0.00059 0.004323
636 CELL ACTIVATION 72 568 0.0005919 0.00433
637 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 12 48 0.0006008 0.004381
638 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 12 48 0.0006008 0.004381
639 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 22 121 0.0006195 0.004511
640 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 8 24 0.0006269 0.004544
641 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 8 24 0.0006269 0.004544
642 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 8 24 0.0006269 0.004544
643 LIPID LOCALIZATION 39 264 0.0006372 0.004611
644 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 58 437 0.0006415 0.004635
645 REGULATION OF CELL ACTIVATION 63 484 0.000643 0.004639
646 REGULATION OF ERK1 AND ERK2 CASCADE 36 238 0.0006499 0.004681
647 DENDRITE MORPHOGENESIS 11 42 0.0006586 0.004729
648 REGULATION OF BONE REMODELING 11 42 0.0006586 0.004729
649 SPECIFICATION OF ORGAN IDENTITY 6 14 0.0006652 0.004747
650 VOCALIZATION BEHAVIOR 6 14 0.0006652 0.004747
651 REGULATION OF SMOOTHENED SIGNALING PATHWAY 14 62 0.0006638 0.004747
652 CAMP CATABOLIC PROCESS 6 14 0.0006652 0.004747
653 REGULATION OF IMMUNE SYSTEM PROCESS 155 1403 0.0006704 0.004777
654 MEMBRANE BIOGENESIS 9 30 0.0006928 0.004902
655 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 7 19 0.000695 0.004902
656 POSITIVE REGULATION OF AXON EXTENSION 10 36 0.0006954 0.004902
657 ENTEROENDOCRINE CELL DIFFERENTIATION 7 19 0.000695 0.004902
658 OLFACTORY LOBE DEVELOPMENT 10 36 0.0006954 0.004902
659 GLOMERULAR EPITHELIUM DEVELOPMENT 7 19 0.000695 0.004902
660 REGULATION OF MEMBRANE REPOLARIZATION 9 30 0.0006928 0.004902
661 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 33 213 0.0007001 0.004924
662 REGULATION OF ANION TRANSPORT 24 138 0.0007006 0.004924
663 IMMUNE SYSTEM DEVELOPMENT 73 582 0.000734 0.005152
664 RECEPTOR MEDIATED ENDOCYTOSIS 35 231 0.0007431 0.005207
665 REGULATION OF BMP SIGNALING PATHWAY 16 77 0.000753 0.005268
666 INORGANIC ION TRANSMEMBRANE TRANSPORT 73 583 0.0007702 0.005381
667 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 18 92 0.0007735 0.005395
668 OUTFLOW TRACT MORPHOGENESIS 13 56 0.0007745 0.005395
669 NEGATIVE REGULATION OF CELL ADHESION 34 223 0.0007841 0.005454
670 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 38 258 0.000786 0.005458
671 REGULATION OF INFLAMMATORY RESPONSE 42 294 0.0008089 0.005609
672 CELL FATE DETERMINATION 11 43 0.0008169 0.005656
673 CELL DEATH 115 1001 0.0008464 0.005852
674 POSITIVE REGULATION OF COAGULATION 8 25 0.0008529 0.005862
675 DOPAMINE METABOLIC PROCESS 8 25 0.0008529 0.005862
676 POSITIVE REGULATION OF CELL GROWTH 25 148 0.0008519 0.005862
677 MALE SEX DIFFERENTIATION 25 148 0.0008519 0.005862
678 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 21 116 0.0008634 0.005925
679 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 16 78 0.0008727 0.005981
680 MATING 10 37 0.0008801 0.005996
681 RESPONSE TO NERVE GROWTH FACTOR 10 37 0.0008801 0.005996
682 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 10 37 0.0008801 0.005996
683 AXON EXTENSION 10 37 0.0008801 0.005996
684 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 12 50 0.0008911 0.006062
685 SKIN EPIDERMIS DEVELOPMENT 15 71 0.0009086 0.006163
686 CELL FATE SPECIFICATION 15 71 0.0009086 0.006163
687 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 165 1517 0.0009123 0.006179
688 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 54 406 0.0009207 0.006227
689 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 14 64 0.0009285 0.00627
690 RELAXATION OF MUSCLE 7 20 0.0009901 0.006648
691 REGULATION OF URINE VOLUME 7 20 0.0009901 0.006648
692 REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT 7 20 0.0009901 0.006648
693 AXONAL FASCICULATION 7 20 0.0009901 0.006648
694 RESPONSE TO BMP 18 94 0.001006 0.006726
695 CELLULAR RESPONSE TO BMP STIMULUS 18 94 0.001006 0.006726
696 ENDOCRINE PROCESS 11 44 0.001005 0.006726
697 DENDRITE DEVELOPMENT 16 79 0.001008 0.006731
698 REGULATION OF DEPHOSPHORYLATION 26 158 0.001012 0.006749
699 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 6 15 0.001028 0.006815
700 CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION 6 15 0.001028 0.006815
701 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 6 15 0.001028 0.006815
702 CELLULAR RESPONSE TO STEROL 6 15 0.001028 0.006815
703 CELLULAR RESPONSE TO RETINOIC ACID 14 65 0.001091 0.007221
704 POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 10 38 0.001103 0.007251
705 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 10 38 0.001103 0.007251
706 PHOSPHOLIPID TRANSPORT 13 58 0.0011 0.007251
707 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 10 38 0.001103 0.007251
708 MESENCHYME MORPHOGENESIS 10 38 0.001103 0.007251
709 POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 8 26 0.00114 0.007448
710 VASODILATION 8 26 0.00114 0.007448
711 RESPONSE TO INTERLEUKIN 6 8 26 0.00114 0.007448
712 RESPONSE TO CORTICOSTERONE 8 26 0.00114 0.007448
713 SALIVARY GLAND DEVELOPMENT 9 32 0.00116 0.007568
714 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 16 80 0.001161 0.007568
715 REGULATION OF CIRCADIAN RHYTHM 19 103 0.001182 0.007689
716 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 23 135 0.001195 0.007765
717 LUNG MORPHOGENESIS 11 45 0.001229 0.007918
718 EMBRYONIC HEART TUBE DEVELOPMENT 15 73 0.001227 0.007918
719 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 11 45 0.001229 0.007918
720 CELLULAR RESPONSE TO KETONE 15 73 0.001227 0.007918
721 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 15 73 0.001227 0.007918
722 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 11 45 0.001229 0.007918
723 REGULATION OF HORMONE LEVELS 61 478 0.001269 0.008165
724 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 14 66 0.001277 0.008194
725 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 14 66 0.001277 0.008194
726 ACTIVATION OF MAPKK ACTIVITY 12 52 0.00129 0.008266
727 REGULATION OF LEUKOCYTE CHEMOTAXIS 18 96 0.001296 0.008293
728 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 13 59 0.001301 0.008317
729 POSITIVE REGULATION OF PROTEIN IMPORT 19 104 0.001331 0.008496
730 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 10 39 0.001371 0.008713
731 REGULATION OF AXON GUIDANCE 10 39 0.001371 0.008713
732 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 10 39 0.001371 0.008713
733 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 7 21 0.001376 0.00872
734 POSITIVE REGULATION OF CIRCADIAN RHYTHM 7 21 0.001376 0.00872
735 CARDIAC MUSCLE ADAPTATION 5 11 0.001404 0.008826
736 POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 5 11 0.001404 0.008826
737 REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 5 11 0.001404 0.008826
738 MUSCLE HYPERTROPHY IN RESPONSE TO STRESS 5 11 0.001404 0.008826
739 REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 5 11 0.001404 0.008826
740 CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS 5 11 0.001404 0.008826
741 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 17 89 0.001412 0.008854
742 POST EMBRYONIC DEVELOPMENT 17 89 0.001412 0.008854
743 REGULATION OF DENDRITE MORPHOGENESIS 15 74 0.001419 0.008884
744 HINDBRAIN DEVELOPMENT 23 137 0.001463 0.009151
745 NEUROMUSCULAR PROCESS 18 97 0.001465 0.009151
746 NEGATIVE REGULATION OF ANION TRANSPORT 9 33 0.001475 0.009176
747 REGULATION OF BONE RESORPTION 9 33 0.001475 0.009176
748 EMBRYONIC EYE MORPHOGENESIS 9 33 0.001475 0.009176
749 DEVELOPMENTAL INDUCTION 8 27 0.001498 0.009223
750 HIPPO SIGNALING 8 27 0.001498 0.009223
751 CELL PROLIFERATION IN FOREBRAIN 8 27 0.001498 0.009223
752 CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 8 27 0.001498 0.009223
753 SUBSTRATE DEPENDENT CELL MIGRATION 8 27 0.001498 0.009223
754 NEURON FATE COMMITMENT 14 67 0.001488 0.009223
755 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 11 46 0.001491 0.009223
756 ODONTOGENESIS 19 105 0.001497 0.009223
757 ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY 6 16 0.001526 0.009353
758 NEGATIVE REGULATION OF CATECHOLAMINE SECRETION 6 16 0.001526 0.009353
759 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 6 16 0.001526 0.009353
760 CHONDROCYTE DIFFERENTIATION 13 60 0.001532 0.009369
761 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 13 60 0.001532 0.009369
762 NEURON PROJECTION EXTENSION 12 53 0.001539 0.009383
763 CYTOSOLIC CALCIUM ION TRANSPORT 12 53 0.001539 0.009383
764 NEGATIVE REGULATION OF NEURON DEATH 27 171 0.001542 0.009392
765 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 61 482 0.001552 0.009439
766 REGULATION OF CYTOSKELETON ORGANIZATION 63 502 0.001614 0.009801
767 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 48 360 0.001631 0.009892
768 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 15 75 0.001635 0.009903
NumGOOverlapSizeP ValueAdj. P Value
1 CALCIUM ION BINDING 123 697 8.51e-15 3.953e-12
2 RECEPTOR BINDING 214 1476 6.211e-15 3.953e-12
3 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 56 228 4.01e-13 1.242e-10
4 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 65 303 4.141e-12 9.617e-10
5 GROWTH FACTOR BINDING 36 123 3.037e-11 5.643e-09
6 ACTIN BINDING 75 393 3.935e-11 6.092e-09
7 MOLECULAR FUNCTION REGULATOR 186 1353 5.205e-11 6.907e-09
8 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 26 81 1.849e-09 2.147e-07
9 CELL ADHESION MOLECULE BINDING 42 186 5.205e-09 5.372e-07
10 CYTOSKELETAL PROTEIN BINDING 119 819 8.69e-09 8.073e-07
11 PDZ DOMAIN BINDING 26 90 2.209e-08 1.866e-06
12 BETA CATENIN BINDING 24 84 9.613e-08 6.445e-06
13 SULFUR COMPOUND BINDING 46 234 9.274e-08 6.445e-06
14 PROTEIN KINASE ACTIVITY 95 640 1.041e-07 6.445e-06
15 GLYCOSAMINOGLYCAN BINDING 42 205 1.004e-07 6.445e-06
16 KINASE ACTIVITY 117 842 1.384e-07 8.033e-06
17 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 93 629 1.705e-07 9.317e-06
18 LIPID BINDING 96 657 1.89e-07 9.753e-06
19 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 20 64 2.221e-07 1.086e-05
20 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 21 70 2.422e-07 1.11e-05
21 ENZYME BINDING 209 1737 2.508e-07 1.11e-05
22 SMAD BINDING 21 72 4.105e-07 1.733e-05
23 PROTEIN DOMAIN SPECIFIC BINDING 90 624 8.08e-07 3.264e-05
24 MACROMOLECULAR COMPLEX BINDING 172 1399 8.443e-07 3.268e-05
25 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 9 16 1.683e-06 6.013e-05
26 TRANSMEMBRANE TRANSPORTER ACTIVITY 129 997 1.657e-06 6.013e-05
27 INTEGRIN BINDING 25 105 2.269e-06 7.808e-05
28 SIGNAL TRANSDUCER ACTIVITY 202 1731 3.405e-06 0.000113
29 HEPARIN BINDING 32 157 3.614e-06 0.0001153
30 RECEPTOR SIGNALING PROTEIN ACTIVITY 34 172 3.722e-06 0.0001153
31 PHOSPHOLIPID BINDING 57 360 5.259e-06 0.0001576
32 COLLAGEN BINDING 18 65 6.153e-06 0.0001786
33 RECEPTOR ACTIVITY 192 1649 7.029e-06 0.0001979
34 KINASE BINDING 84 606 8.976e-06 0.0002453
35 PROTEIN COMPLEX BINDING 119 935 9.274e-06 0.0002462
36 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 68 464 1.033e-05 0.0002667
37 ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES 26 121 1.073e-05 0.0002694
38 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 52 328 1.291e-05 0.0003157
39 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 124 992 1.425e-05 0.0003395
40 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 19 77 2.112e-05 0.0004905
41 CALMODULIN BINDING 33 179 2.354e-05 0.0005335
42 PHOSPHOLIPID TRANSPORTER ACTIVITY 14 48 3.457e-05 0.0007646
43 LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 7 13 3.761e-05 0.0008126
44 CHANNEL REGULATOR ACTIVITY 26 131 4.616e-05 0.0009697
45 TRANSPORTER ACTIVITY 150 1276 4.697e-05 0.0009697
46 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 38 226 5.037e-05 0.001017
47 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 20 90 6.551e-05 0.001295
48 HISTONE ACETYLTRANSFERASE BINDING 10 28 6.797e-05 0.001315
49 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 48 315 7.568e-05 0.001435
50 GATED CHANNEL ACTIVITY 49 325 8.393e-05 0.001559
51 RHO GTPASE BINDING 18 78 8.91e-05 0.001611
52 REGULATORY REGION NUCLEIC ACID BINDING 102 818 9.019e-05 0.001611
53 PROTEIN TYROSINE KINASE ACTIVITY 31 176 9.996e-05 0.001752
54 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 7 15 0.0001208 0.002004
55 LOW DENSITY LIPOPROTEIN PARTICLE BINDING 7 15 0.0001208 0.002004
56 ALCOHOL BINDING 21 101 0.0001206 0.002004
57 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 9 25 0.0001469 0.002352
58 TRANSLATION REPRESSOR ACTIVITY 8 20 0.0001468 0.002352
59 TRANSCRIPTION FACTOR BINDING 70 524 0.0001545 0.002432
60 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 58 417 0.0001919 0.002971
61 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 43 0.0001981 0.002979
62 LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 7 16 0.0001988 0.002979
63 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 19 90 0.0002026 0.002987
64 ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 51 356 0.0002228 0.003234
65 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 138 1199 0.0002438 0.003485
66 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 13 51 0.0002928 0.004121
67 CATION CHANNEL ACTIVITY 44 298 0.0003012 0.004177
68 CYCLASE ACTIVITY 8 22 0.0003186 0.00429
69 WNT ACTIVATED RECEPTOR ACTIVITY 8 22 0.0003186 0.00429
70 HORMONE BINDING 15 65 0.0003364 0.004465
71 PROTEIN SERINE THREONINE KINASE ACTIVITY 60 445 0.000347 0.00454
72 STEROID HORMONE RECEPTOR ACTIVITY 14 59 0.0003876 0.005001
73 POTASSIUM CHANNEL REGULATOR ACTIVITY 12 46 0.0003943 0.005018
74 VOLTAGE GATED ION CHANNEL ACTIVITY 31 190 0.0004095 0.00514
75 G PROTEIN COUPLED RECEPTOR BINDING 39 259 0.0004349 0.005387
76 ZINC ION BINDING 132 1155 0.0004439 0.0054
77 ADENYL NUCLEOTIDE BINDING 167 1514 0.0004476 0.0054
78 ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 14 60 0.000466 0.00555
79 PHOSPHATIDYLINOSITOL BINDING 32 200 0.0004747 0.005582
80 KINASE INHIBITOR ACTIVITY 18 89 0.0005114 0.005939
81 BETA AMYLOID BINDING 10 35 0.0005438 0.006237
82 PROTEIN LIPID COMPLEX BINDING 8 24 0.0006269 0.007017
83 ACTIN FILAMENT BINDING 22 121 0.0006195 0.007017
84 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 46 329 0.0007511 0.008307
85 VIRUS RECEPTOR ACTIVITY 15 70 0.0007776 0.008445
86 CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 77 622 0.0007817 0.008445
87 SH3 DOMAIN BINDING 21 116 0.0008634 0.009219
88 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 12 50 0.0008911 0.009407
89 WNT PROTEIN BINDING 9 31 0.0009023 0.009419
90 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 19 101 0.0009249 0.009547
NumGOOverlapSizeP ValueAdj. P Value
1 INTRINSIC COMPONENT OF PLASMA MEMBRANE 256 1649 7.403e-22 1.441e-19
2 CELL PROJECTION 272 1786 5.156e-22 1.441e-19
3 MEMBRANE REGION 196 1134 4.776e-22 1.441e-19
4 SYNAPSE 143 754 6.6e-20 9.636e-18
5 CELL JUNCTION 190 1151 4.116e-19 4.807e-17
6 PLASMA MEMBRANE REGION 159 929 1.436e-17 1.397e-15
7 NEURON PART 193 1265 1.01e-15 8.428e-14
8 NEURON PROJECTION 155 942 1.382e-15 1.009e-13
9 CELL SURFACE 132 757 2.204e-15 1.43e-13
10 PROTEINACEOUS EXTRACELLULAR MATRIX 79 356 2.796e-15 1.633e-13
11 EXTRACELLULAR MATRIX 88 426 6.774e-15 3.597e-13
12 MEMBRANE MICRODOMAIN 65 288 3.64e-13 1.772e-11
13 EXTRACELLULAR MATRIX COMPONENT 37 125 1.119e-11 5.027e-10
14 BASEMENT MEMBRANE 30 93 9.278e-11 3.87e-09
15 POSTSYNAPSE 71 378 2.732e-10 1.064e-08
16 SYNAPSE PART 99 610 5.065e-10 1.849e-08
17 RECEPTOR COMPLEX 63 327 9.674e-10 3.323e-08
18 CELL CELL JUNCTION 70 383 1.242e-09 4.031e-08
19 CELL PROJECTION PART 136 946 1.44e-09 4.427e-08
20 SOMATODENDRITIC COMPARTMENT 102 650 1.822e-09 5.32e-08
21 DENDRITE 77 451 4.59e-09 1.276e-07
22 PLASMA MEMBRANE PROTEIN COMPLEX 84 510 5.261e-09 1.396e-07
23 CELL LEADING EDGE 64 350 6.214e-09 1.578e-07
24 APICAL JUNCTION COMPLEX 33 128 7.102e-09 1.728e-07
25 APICAL PLASMA MEMBRANE 56 292 9.703e-09 2.267e-07
26 EXCITATORY SYNAPSE 42 197 3.069e-08 6.894e-07
27 ANCHORING JUNCTION 79 489 3.556e-08 7.691e-07
28 AXON 70 418 5.085e-08 1.061e-06
29 SARCOLEMMA 31 125 5.336e-08 1.075e-06
30 I BAND 30 121 8.765e-08 1.706e-06
31 APICAL PART OF CELL 62 361 1.164e-07 2.194e-06
32 PLASMA MEMBRANE RAFT 24 86 1.569e-07 2.863e-06
33 CELL SUBSTRATE JUNCTION 66 398 1.772e-07 3.135e-06
34 BASOLATERAL PLASMA MEMBRANE 41 211 6.266e-07 1.076e-05
35 GOLGI APPARATUS 176 1445 1.139e-06 1.9e-05
36 LAMELLIPODIUM 35 172 1.341e-06 2.176e-05
37 CONTRACTILE FIBER 40 211 1.644e-06 2.595e-05
38 EXTRACELLULAR SPACE 168 1376 1.757e-06 2.7e-05
39 GLYCOPROTEIN COMPLEX 10 21 3.205e-06 4.799e-05
40 CELL BODY 73 494 3.66e-06 5.344e-05
41 ACTIN BASED CELL PROJECTION 35 181 4.531e-06 6.453e-05
42 VACUOLE 144 1180 1.03e-05 0.0001411
43 INTRACELLULAR VESICLE 152 1259 1.039e-05 0.0001411
44 ENDOSOME 103 793 1.598e-05 0.0002121
45 CELL PROJECTION MEMBRANE 48 298 1.795e-05 0.000233
46 CELL CELL CONTACT ZONE 17 64 2.022e-05 0.0002567
47 SITE OF POLARIZED GROWTH 29 149 2.542e-05 0.000314
48 EXTRINSIC COMPONENT OF MEMBRANE 42 252 2.581e-05 0.000314
49 NEURONAL POSTSYNAPTIC DENSITY 15 53 2.717e-05 0.0003239
50 SIDE OF MEMBRANE 62 428 3.561e-05 0.0004159
51 COLLAGEN TRIMER 20 88 4.667e-05 0.0005345
52 AXON PART 37 219 5.663e-05 0.000636
53 ACTIN CYTOSKELETON 63 444 5.78e-05 0.0006369
54 COMPLEX OF COLLAGEN TRIMERS 9 23 6.884e-05 0.0007445
55 INTERCALATED DISC 14 51 7.245e-05 0.0007493
56 POSTSYNAPTIC MEMBRANE 35 205 7.133e-05 0.0007493
57 T TUBULE 13 45 7.314e-05 0.0007493
58 FILOPODIUM 20 94 0.0001244 0.001253
59 ENDOPLASMIC RETICULUM 182 1631 0.0001353 0.001339
60 AXONAL GROWTH CONE 8 20 0.0001468 0.001429
61 EXTERNAL SIDE OF PLASMA MEMBRANE 38 238 0.0001547 0.001481
62 PLATELET ALPHA GRANULE 17 75 0.000175 0.001648
63 CATION CHANNEL COMPLEX 29 167 0.0002123 0.001968
64 SYNAPTIC MEMBRANE 40 261 0.0002558 0.002334
65 BASAL PART OF CELL 13 51 0.0002928 0.002631
66 ENDOCYTIC VESICLE 39 256 0.0003431 0.003036
67 TRANSPORTER COMPLEX 46 321 0.0004385 0.003822
68 NEUROMUSCULAR JUNCTION 13 54 0.000534 0.004586
69 ANCHORED COMPONENT OF MEMBRANE 26 152 0.0005581 0.004723
70 PLATELET ALPHA GRANULE LUMEN 13 55 0.0006449 0.00538
71 INTERSTITIAL MATRIX 6 14 0.0006652 0.005471
72 SECRETORY GRANULE 48 352 0.001012 0.008211
73 LEADING EDGE MEMBRANE 23 134 0.001077 0.008619

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 cGMP_PKG_signaling_pathway_hsa04022 39 163 3.22e-09 1.674e-07
2 Rap1_signaling_pathway_hsa04015 44 206 1.369e-08 3.56e-07
3 MAPK_signaling_pathway_hsa04010 55 295 3.614e-08 6.265e-07
4 Wnt_signaling_pathway_hsa04310 34 146 6.575e-08 8.504e-07
5 Calcium_signaling_pathway_hsa04020 39 182 8.177e-08 8.504e-07
6 Focal_adhesion_hsa04510 41 199 1.209e-07 1.048e-06
7 cAMP_signaling_pathway_hsa04024 39 198 8.163e-07 6.064e-06
8 PI3K_Akt_signaling_pathway_hsa04151 57 352 2.591e-06 1.684e-05
9 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 29 139 6.301e-06 3.466e-05
10 Hippo_signaling_pathway_hsa04390 31 154 6.665e-06 3.466e-05
11 ECM_receptor_interaction_hsa04512 20 82 1.556e-05 7.354e-05
12 Tight_junction_hsa04530 32 170 2.019e-05 8.747e-05
13 Hedgehog_signaling_pathway_hsa04340 14 47 2.658e-05 0.0001063
14 Gap_junction_hsa04540 20 88 4.667e-05 0.0001734
15 Ras_signaling_pathway_hsa04014 38 232 8.961e-05 0.0003107
16 Adherens_junction_hsa04520 17 72 0.0001025 0.0003214
17 Cell_adhesion_molecules_.CAMs._hsa04514 27 145 0.0001051 0.0003214
18 Phospholipase_D_signaling_pathway_hsa04072 27 146 0.0001185 0.0003424
19 Regulation_of_actin_cytoskeleton_hsa04810 34 208 0.0002132 0.0005836
20 ABC_transporters_hsa02010 12 45 0.0003159 0.0008215
21 TGF_beta_signaling_pathway_hsa04350 17 84 0.0007177 0.001777
22 Sphingolipid_signaling_pathway_hsa04071 21 118 0.001084 0.002563
23 Apelin_signaling_pathway_hsa04371 22 137 0.003243 0.007333
24 FoxO_signaling_pathway_hsa04068 21 132 0.004436 0.009606
25 Oocyte_meiosis_hsa04114 20 124 0.004618 0.009606
26 HIF_1_signaling_pathway_hsa04066 17 100 0.005038 0.01008
27 AMPK_signaling_pathway_hsa04152 18 121 0.01565 0.03015
28 Notch_signaling_pathway_hsa04330 9 48 0.01997 0.03709
29 ErbB_signaling_pathway_hsa04012 13 85 0.0297 0.05326
30 Cytokine_cytokine_receptor_interaction_hsa04060 32 270 0.04084 0.07079
31 mTOR_signaling_pathway_hsa04150 19 151 0.06092 0.1022
32 Jak_STAT_signaling_pathway_hsa04630 20 162 0.06523 0.106
33 Cellular_senescence_hsa04218 19 160 0.09541 0.1503
34 Hippo_signaling_pathway_multiple_species_hsa04392 5 29 0.09941 0.152
35 p53_signaling_pathway_hsa04115 9 68 0.1288 0.1914
36 Phosphatidylinositol_signaling_system_hsa04070 12 99 0.144 0.2079
37 Phagosome_hsa04145 17 152 0.1614 0.2268
38 Peroxisome_hsa04146 10 83 0.1761 0.241
39 Neuroactive_ligand_receptor_interaction_hsa04080 28 278 0.2196 0.2928
40 Ferroptosis_hsa04216 5 40 0.2597 0.3377
41 Apoptosis_hsa04210 13 138 0.4114 0.5218
42 Lysosome_hsa04142 11 123 0.4954 0.6134
43 Autophagy_other_hsa04136 3 32 0.529 0.6397
44 VEGF_signaling_pathway_hsa04370 5 59 0.5832 0.6892
45 Autophagy_animal_hsa04140 10 128 0.6738 0.7786
46 Endocytosis_hsa04144 18 244 0.7883 0.8743
47 Apoptosis_multiple_species_hsa04215 2 33 0.7902 0.8743
48 Mitophagy_animal_hsa04137 4 65 0.8227 0.8821
49 TNF_signaling_pathway_hsa04668 7 108 0.8328 0.8821
50 Cell_cycle_hsa04110 8 124 0.8482 0.8821
51 NF_kappa_B_signaling_pathway_hsa04064 5 95 0.9207 0.9387
52 Necroptosis_hsa04217 8 164 0.976 0.976

Quest ID: d378f71e68e8a5d953713299000a797f